Biomarkers for Oxidative Stress: Clinical Application in Pediatric Medicine

Abstract

Loads of reactive oxygen species (ROS), including superoxide anion and nitric oxide, that overburden antioxidant systems induce oxidative stress in the body. Major cellular targets of ROS are membrane lipids, proteins, nucleic acids, and carbohydrates. Circumstantial evidence suggests that ROS play a crucial role in the initiation and progression of various diseases in children and adolescents. The involvement of ROS and oxidative stress in pediatric diseases is an important concern, but oxidative stress status in young subjects and appropriate methods for its measurement remain to be defined. Recently, specific biomarkers for oxidative damage and antioxidant defense have been introduced into the field of pediatric medicine. This review is intended to provide an overview of clinical applications of oxidative stress biomarkers in the field of pediatric medicine. First, this review presents the biochemistry and pathophysiology of ROS and antioxidant defense systems. Second, it presents a list of clinically applicable biomarkers, along with pediatric diseases in which enhanced oxidative stress might be involved. The discussion emphasizes that several reliable biomarkers are easily measurable using enzyme-linked immunosorbent assay. Third, this review presents age-related reference normal ranges of oxidative stress biomarkers, including urinary acrolein-lysine, 8-hydroxy-2'-deoxyguanosine, nitrite/nitrate, and pentosidine, and the changes of the parameters in several clinical conditions, including atopic dermatitis and diabetes mellitus. New and interesting data on oxidative stress and antioxidant defenses in neonatal biology are also presented. Fourth, this review discusses the ever-accumulating body of data linking oxidative stress to disturbances of the nitric oxide system and vascular endothelial activation/dysfunction. Finally, this review describes the reported clinical trials that have evaluated the efficacy of antioxidants for oxidative-stress related diseases. Suggestions are advanced for the direction of future trials using antioxidant therapies. Repeated measurement of appropriate parameters will enable us to discern the pathophysiological patterns of pediatric diseases and guide our therapies appropriately.

Comparative Study of Atherosclerotic Parameters in Mongolian and Japanese Patients with Hypertension and Diabetes Mellitus

“…The lowered effect of high altitude on plasma glucose has also been reported 24) , and in fact our studied Mongolian DM patients had lower glucose levels. From the biological viewpoint in association with altitude, an increase in oxidative stress (via reactive oxygen metabolism) in Mongolian people compared with Japanese people 25,26) has been reported, and this may cause differences in atherosclerotic parameters 27) . Additionally, genetic factors could have played roles in the present results.…”

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

“…Biomedical fields such as neurochemistry, psychoneuroendocrinology and psychoneuroimmunology are major contributors in this respect, and neurochemistry, in particular, informs most of the current biological treatments. In a similar vein, oxidation biology is emerging as a promising avenue of investigation, and has been actively pursued in other areas of medicine (Barnham et al, 2004;Mehta et al, 2006;Tsukahara, 2007).…”

Ionizing irradiation induces apoptotic damage of salivary gland acinar cells via NADPH oxidase 1-dependent superoxide generation

“…However, it has been supposed that reactive oxygen species (ROS) are involved in the impairment of salivary gland function due to aging, inflammation, drugs, and ionizing irradiation [1][2][3][4]. Not only extracellular but also intracellular ROS regulate cellular biological activities by activation and also suppression of proteins as well as by modification of DNA [5][6][7]. To eliminate the damage by ROS, all kinds of animal and plant cells possess ROS-scavenging and ROS-inactivation systems.…”